vs
Side-by-side financial comparison of Addex Therapeutics Ltd. (ADXN) and Youxin Technology Ltd (YAAS). Click either name above to swap in a different company.
Youxin Technology Ltd is the larger business by last-quarter revenue ($39.4K vs $33.0K, roughly 1.2× Addex Therapeutics Ltd.). Youxin Technology Ltd runs the higher net margin — -324.8% vs -5256.7%, a 4931.9% gap on every dollar of revenue.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company specializing in the discovery and development of innovative allosteric modulator therapies for underserved neurological and psychiatric disorders. It operates in global biopharmaceutical markets, with a pipeline targeting rare and common central nervous system conditions to address unmet patient needs.
Youxin Technology Ltd is a China-based automotive digital service provider. It operates used car trading platforms, offers new car sales support, auto financing referrals, and after-sales resource matching for consumers and auto industry participants across mainland China, focusing on optimizing vehicle transaction efficiency.
ADXN vs YAAS — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $33.0K | $39.4K |
| Net Profit | $-1.7M | $-127.9K |
| Gross Margin | — | 67.9% |
| Operating Margin | -2320.0% | — |
| Net Margin | -5256.7% | -324.8% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-374.6K |
| Total Assets | — | $132.2K |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | $-374.6K |
| Q3 25 | — | — | ||
| Q2 25 | — | $132.2K |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7K | $-88.6K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-1.7K | — | ||
| Q2 25 | — | $-88.6K |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
